PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Endocrinology and Metabolism10.3803/enm.2014.29.2.2082014292208Response: Diagnostic Whole-Body Scan May Not Be Necessary for Intermediate-Risk Patients with Differentiated Thyroid Cancer after Low-Dose (30 mCi) Radioactive Iodide Ablation (Endocrinol Metab 2014;29:33-9, Eon Ju Jeon et al.)Eon Ju Jeon, Eui Dal Junghttps://synapse.koreamed.org/DOIx.php?id=10.3803/EnM.2014.29.2.208, https://synapse.koreamed.org/pdf/10.3803/EnM.2014.29.2.208, http://synapse.koreamed.org/DOIx.php?id=10.3803/EnM.2014.29.2.208
Endocrinology and Metabolism10.3803/enm.2014.29.2.2062014292206Letter: Diagnostic Whole-Body Scan May Not Be Necessary for Intermediate-Risk Patients with Differentiated Thyroid Cancer after Low-Dose (30 mCi) Radioactive Iodide Ablation (Endocrinol Metab 2014;29:33-9, Eon Ju Jeon et al.)Chan-Hee Junghttps://synapse.koreamed.org/DOIx.php?id=10.3803/EnM.2014.29.2.206, https://synapse.koreamed.org/pdf/10.3803/EnM.2014.29.2.206, http://synapse.koreamed.org/DOIx.php?id=10.3803/EnM.2014.29.2.206
Endocrinology and Metabolism10.3803/enm.2014.29.1.33201429133Diagnostic Whole-Body Scan May Not Be Necessary for Intermediate-Risk Patients with Differentiated Thyroid Cancer after Low-Dose (30 mCi) Radioactive Iodide AblationEon Ju Jeon, Eui Dal Junghttps://synapse.koreamed.org/DOIx.php?id=10.3803/EnM.2014.29.1.33, https://synapse.koreamed.org/pdf/10.3803/EnM.2014.29.1.33, http://synapse.koreamed.org/DOIx.php?id=10.3803/EnM.2014.29.1.33
Journal of Endocrinological Investigation10.1007/s40618-017-0704-020174091023-1023Anti-thyroglobulin antibodies and risk of finding iodine avid metastases on post-radioactive iodine ablation scan in low-risk thyroid cancer patientsP. W. Rosariohttp://link.springer.com/article/10.1007/s40618-017-0704-0/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40618-017-0704-0.pdf, http://link.springer.com/content/pdf/10.1007/s40618-017-0704-0.pdf
Otolaryngology–Head and Neck Surgery10.1177/01945998209669822020019459982096698Preablation Diagnostic Whole-Body Scan vs Empiric Radioactive Iodine Ablation in Differentiated Thyroid Cancer: Cost-effectiveness AnalysisSimran Arjani, Patrick L. Quinn, Ravi J. Chokshihttp://journals.sagepub.com/doi/pdf/10.1177/0194599820966982, http://journals.sagepub.com/doi/full-xml/10.1177/0194599820966982, http://journals.sagepub.com/doi/pdf/10.1177/0194599820966982
Journal of the American College of Surgeons10.1016/j.jamcollsurg.2020.07.13320202314S74-S75Cost-Effectiveness of Pre-Ablation Diagnostic Whole-Body Scan vs Empiric Radioactive Iodine Ablation in Differentiated Thyroid CancerSimran Arjani, Patrick L. Quinn, Ravi J. Chokshihttps://api.elsevier.com/content/article/PII:S1072751520307080?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1072751520307080?httpAccept=text/plain
BMC Cancer10.1186/s12885-020-07029-32020201Longer-term recurrence rate after low versus high dose radioiodine ablation for differentiated thyroid Cancer in low and intermediate risk patients: a meta-analysisI. Vardarli, F. Weidemann, M. Aboukoura, K. Herrmann, I. Binse, R. Görgeshttps://link.springer.com/content/pdf/10.1186/s12885-020-07029-3.pdf, https://link.springer.com/article/10.1186/s12885-020-07029-3/fulltext.html, https://link.springer.com/content/pdf/10.1186/s12885-020-07029-3.pdf
Clinical Thyroidology10.1089/ct.2017;29.55-57201729255-57Recurrence Rates in Patients with Intermediate-Risk Differentiated Thyroid Cancer Are Similar after Low-Dose and High-Dose Radioiodine Ablation in a Korean SeriesMartin Biermannhttp://www.liebertpub.com/doi/full-xml/10.1089/ct.2017%3B29.55-57, http://www.liebertpub.com/doi/pdf/10.1089/ct.2017%3B29.55-57
European Thyroid Journal10.1159/00049429020188290-95Less than 2% of the Low- and Intermediate-Risk Differentiated Thyroid Cancers Show Distant Metastases at Post-Ablation Whole-Body ScanLaura Agate, Francesca Bianchi, Federica Brozzi, Pierina Santini, Eleonora Molinaro, Valeria Bottici, David Viola, Loredana Lorusso, Paolo Vitti, Rossella Eliseihttps://www.karger.com/Article/Pdf/494290, https://www.karger.com/Article/Pdf/494290
Yearbook of Endocrinology10.1016/s0084-3741(08)70389-520062006306-309Are There Disadvantages in Administering 131I Ablation Therapy in Patients With Differentiated Thyroid Carcinoma Without a Preablative Diagnostic 131I Whole-Body Scan?E.L. Mazzaferrihttps://api.elsevier.com/content/article/PII:S0084374108703895?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0084374108703895?httpAccept=text/plain